Creating a Global Company

Rest of World Markets at a glance Market Presence Product Portfolio Focus Sales Force Amongst the leading Indian Companies Local Manufacturing Japan Presence • Across all major markets in Western Europe, Canada, A&NZ, Japan, Israel and other markets Expanding basket of products including specialty brands, SUN PHARMA injectable & hospital products as well as products for retail market • Development and commercialization of complex generics and differentiated products to drive sustainable and profitable growth • • Distribution led model • Sales force for Specialty products . • At Canada, Japan, Australia, Israel and Hungary + supplies from India facilities • Acquired 14 established prescription brands from Novartis in March 2016 • Acquired Pola Pharma in Japan in Jan 2019 Canada Presence • Launched Ilumya in Japan in September 2020 • Portfolio of generics and specialty products • Specialty products - Launched Ilumya in October 2021 and Cequa in January 2022 32

View entire presentation